2025-04-03 23:46:26
Ace Investor, Mr. Utpal Sheth Invests in Parag Milk Foods
Marico Ltd - Quarterly Update: Q4 FY25
Rama Steel Tubes Ltd announces sales volume for Q4FY25 and FY2025
Qatar Energy LNG includes Man Industries India Ltd to its approved vendor listStock Report
Morepen Laboratories Ltd posts consolidated PAT of Rs. 8.99 crores in Q3FY23
Posted On : 2023-02-14 12:01:17( TIMEZONE : IST )
Morepen Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 349.6881 crores during the period ended December 31, 2022 as compared to Rs. 403.8524 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 8.9935 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 15.8112 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.16 for the period ended December 31, 2022 as compared to Rs. 0.33 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹349.6881 crs | ₹403.8524 crs |  -13.41% |
| Net Profit | ₹8.9935 crs | ₹15.8112 crs | -43.12% |
| EPS | ₹0.16 | ₹0.33 | -51.52% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.349.6881 crores during the period ended December 31, 2022 as compared to Rs.399.1902 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.8.9935 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.21.5214 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.16 for the period ended December 31, 2022 as compared to Rs.0.41 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹349.6881 crs | ₹399.1902 crs | -12.40% |
| Net Profit | ₹8.9935 crs | ₹21.5214 crs | -58.21% |
| EPS | ₹0.16 | ₹0.41 | -60.98% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.1056.8554 crores during the 9 Months period ended December 31, 2022 as compared to Rs.1185.6707 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.30.4348 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.89.3595 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.0.60 for the 9 Months period ended December 31, 2022 as compared to Rs.1.72 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹1056.8554 crs | ₹1185.6707 crs | -10.86% |
| Net Profit | ₹30.4348 crs | ₹89.3595 crs | -65.94% |
| EPS | ₹0.60 | ₹1.72 | -65.12% |
Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 27.40 as compared to the previous close of Rs. 28.45. The total number of shares traded during the day was 555976 in over 2962 trades.
The stock hit an intraday high of Rs. 28.80 and intraday low of 26.95. The net turnover during the day was Rs. 15415966.00.
